• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 17, 2019

Inhibiting tankyrase to treat osteoarthritis and regenerate cartilage

Read More
BioCentury | Jan 18, 2018
Translation in Brief

A notch for tankyrase

NYU paper identifies new cancer opportunities for tankyrase inhibitors
Read More
BioCentury | Jul 14, 2017
Company News

Eisai grants 2XOncology rights to 2X-121

Read More
BioCentury | Nov 23, 2015
Strategy

More with less

How Merck KGaA's new R&D chief is shaping the pipeline
Read More
BioCentury | Nov 24, 2014
Company News

Merck KGaA, Institute of Cancer Research, Wellcome Trust deal

Read More
BioCentury | Nov 13, 2014
Translation in Brief

Translational tidbits

Read More
BioCentury | May 29, 2014
Distillery Therapeutics

Indication: Cancer

Read More
BioCentury | Aug 22, 2013
Distillery Therapeutics

Indication: Cancer

Read More
BioCentury | Apr 25, 2013
Distillery Therapeutics

Indication: Cancer

Read More
BioCentury | Apr 18, 2013
Cover Story

Targeting tankyrase

Read More
Items per page:
1 - 10 of 17